Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Increased iron in HCV infection: collateral damage or antiviral defense?

Mueller S.

J Hepatol. 2010 Dec;53(6):990-2. doi: 10.1016/j.jhep.2010.08.003. Epub 2010 Aug 22. No abstract available.

2.

Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells.

Fillebeen C, Pantopoulos K.

J Hepatol. 2010 Dec;53(6):995-9. doi: 10.1016/j.jhep.2010.04.044. Epub 2010 Aug 1.

PMID:
20813419
3.

Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C.

Mifuji R, Kobayashi Y, Ma N, Qiang QL, Urawa N, Horiike S, Iwasa M, Kaito M, Malavasi F, Adachi Y.

J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):144-51.

PMID:
16706826
4.

Role of iron in the natural history and clinical course of hepatitis C disease.

Shedlofsky SI.

Hepatogastroenterology. 1998 Mar-Apr;45(20):349-55. Review.

PMID:
9638405
5.

Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.

Fontana RJ, Israel J, LeClair P, Banner BF, Tortorelli K, Grace N, Levine RA, Fiarman G, Thiim M, Tavill AS, Bonkovsky HL.

Hepatology. 2000 Mar;31(3):730-6.

6.

Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.

Fujita N, Horiike S, Sugimoto R, Tanaka H, Iwasa M, Kobayashi Y, Hasegawa K, Ma N, Kawanishi S, Adachi Y, Kaito M.

Free Radic Biol Med. 2007 Feb 1;42(3):353-62. Epub 2006 Nov 6.

PMID:
17210448
7.

Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.

Sebastiani G, Vario A, Ferrari A, Pistis R, Noventa F, Alberti A.

J Viral Hepat. 2006 Mar;13(3):199-205.

PMID:
16475996
8.

Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.

Fargion S, Fracanzani AL, Rossini A, Borzio M, Riggio O, Belloni G, Bissoli F, Ceriani R, Ballarè M, Massari M, Trischitta C, Fiore P, Orlandi A, Morini L, Mattioli M, Oldani S, Cesana B, Fiorelli G.

Am J Gastroenterol. 2002 May;97(5):1204-10.

PMID:
12014729
9.

Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy.

Pereira Pda S, Silva IS, Uehara SN, Emori CT, Lanzoni VP, Silva AE, Ferraz ML.

Rev Inst Med Trop Sao Paulo. 2009 Oct-Dec;51(6):331-6.

10.

Hepatic steatosis and hepatitis C: Still unhappy bedfellows?

Hwang SJ, Lee SD.

J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:96-101. doi: 10.1111/j.1440-1746.2010.06542.x. Review.

PMID:
21199519
11.

Predictive value of the phosphorylation of signal transducers and activators of transcription in the outcome of interferon therapy for chronic hepatitis C.

Miyaaki H, Ichikawa T, Nakao K, Takeshita S, Shibata H, Ozawa E, Akiyama M, Miuma S, Eguchi K.

Intervirology. 2008;51(6):394-9. doi: 10.1159/000205264. Epub 2009 Mar 4.

PMID:
19258717
12.
13.

Liver iron accumulation in chronic hepatitis C patients without HFE mutations: relationships with histological damage, viral load and genotype and alpha-glutathione S-transferase levels.

Giannini E, Mastracci L, Botta F, Romagnoli P, Fasoli A, Risso D, Faravelli F, Ceppa P, Lantieri PB, Icardi GC, Testa R.

Eur J Gastroenterol Hepatol. 2001 Nov;13(11):1355-61.

PMID:
11692063
14.

Influence of Helicobacter pylori infection on iron accumulation in hepatitis C.

Sumida Y, Kanemasa K, Yamaoka Y, Imamura S, Katoh N, Nakashima T, Tachibana S, Mitsuyoshi H, Itoh Y, Okanoue T.

Liver Int. 2006 Sep;26(7):827-33.

PMID:
16911465
15.

Relationship between iron concentration and hepatitis C virus RNA level in liver tissue.

Cotler SJ, Emond MJ, Gretch DR, Wilson JJ, Lin M, Bronner MP, Kowdley KV.

J Clin Gastroenterol. 1999 Dec;29(4):322-6.

PMID:
10599634
16.

Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.

Bautista D, Bermúdez-Silva FJ, Lasarte JJ, Rodriguez-Fonseca F, Baixeras E.

J Pathol. 2007 Nov;213(3):347-55.

PMID:
17940994
17.

Antiviral therapy: why does it fail in HCV-related chronic hepatitis?

Masarone M, Persico M.

Expert Rev Anti Infect Ther. 2011 May;9(5):535-43. doi: 10.1586/eri.11.10. Review.

PMID:
21609265
18.

Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirin.

Fiel MI, Schiano TD, Guido M, Thung SN, Lindsay KL, Davis GL, Lewis JH, Seeff LB, Bodenheimer HC Jr.

Am J Clin Pathol. 2000 Jan;113(1):35-9.

PMID:
10631856
19.

Iron regulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3.

Theurl I, Zoller H, Obrist P, Datz C, Bachmann F, Elliott RM, Weiss G.

J Infect Dis. 2004 Aug 15;190(4):819-25. Epub 2004 Jul 16.

PMID:
15272411
20.

Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.

Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P.

Am J Gastroenterol. 2003 May;98(5):1150-4.

PMID:
12809841

Supplemental Content

Support Center